West Pharmaceutical Services Shares Outstanding 2010-2024 | WST

West Pharmaceutical Services shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • West Pharmaceutical Services shares outstanding for the quarter ending March 31, 2024 were 0.074B, a 1.85% decline year-over-year.
  • West Pharmaceutical Services 2023 shares outstanding were 0.075B, a 0.66% decline from 2022.
  • West Pharmaceutical Services 2022 shares outstanding were 0.076B, a 0.66% decline from 2021.
  • West Pharmaceutical Services 2021 shares outstanding were 0.076B, a 0.66% increase from 2020.
West Pharmaceutical Services Annual Shares Outstanding
(Millions of Shares)
2023 75
2022 76
2021 76
2020 76
2019 75
2018 75
2017 76
2016 75
2015 74
2014 73
2013 71
2012 72
2011 74
2010 73
2009 73
West Pharmaceutical Services Quarterly Shares Outstanding
(Millions of Shares)
2024-03-31 74
2023-12-31 75
2023-09-30 75
2023-06-30 75
2023-03-31 76
2022-12-31 76
2022-09-30 76
2022-06-30 76
2022-03-31 76
2021-12-31 76
2021-09-30 76
2021-06-30 76
2021-03-31 76
2020-12-31 76
2020-09-30 76
2020-06-30 76
2020-03-31 76
2019-12-31 75
2019-09-30 76
2019-06-30 75
2019-03-31 75
2018-12-31 75
2018-09-30 76
2018-06-30 75
2018-03-31 76
2017-12-31 76
2017-09-30 76
2017-06-30 76
2017-03-31 75
2016-12-31 75
2016-09-30 75
2016-06-30 75
2016-03-31 74
2015-12-31 74
2015-09-30 74
2015-06-30 74
2015-03-31 73
2014-12-31 73
2014-09-30 73
2014-06-30 72
2014-03-31 72
2013-12-31 71
2013-09-30 71
2013-06-30 71
2013-03-31 70
2012-12-31 72
2012-09-30 69
2012-06-30 73
2012-03-31 74
2011-12-31 74
2011-09-30 74
2011-06-30 74
2011-03-31 74
2010-12-31 73
2010-09-30 73
2010-06-30 73
2010-03-31 73
2009-12-31 73
2009-09-30 73
2009-06-30 72
2009-03-31 72
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $26.385B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.394B 19.11
Becton Dickinson (BDX) United States $66.895B 19.43
Cardinal Health (CAH) United States $25.104B 15.09
Align Technology (ALGN) United States $23.254B 44.92
Cooper (COO) United States $17.657B 26.72
Labcorp (LH) United States $16.691B 14.40
Henry Schein (HSIC) United States $9.396B 16.25
DENTSPLY SIRONA (XRAY) United States $6.339B 16.70
Merit Medical Systems (MMSI) United States $4.284B 24.51
Patterson (PDCO) United States $2.309B 11.06
STAAR Surgical (STAA) United States $2.307B 72.25
CONMED (CNMD) United States $2.025B 18.37
Atrion (ATRI) United States $0.695B 35.81
Lifevantage (LFVN) United States $0.080B 12.89
Pro-Dex (PDEX) United States $0.066B 24.91
Biolase (BIOL) United States $0.005B 0.00